BAX and Alzheimer disease: The ratio of Bax transcripts without exon 2 over the total Bax transcripts was statistically significantly higher in the AD group than the control (p = 0.0096) (Figure 2b), mostly contributed by female AD patients (Figure 2c), not male patients (Figure 2d).